Literature DB >> 15708833

Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes.

José Cunha-Vaz1, Rui Bernardes.   

Abstract

This review addresses the initial stages of nonproliferative diabetic retinopathy in diabetes type 2. The natural history of the initial lesions occurring in the diabetic retina has particular relevance for our understanding and management of diabetic retinal disease, one of the major causes of vision loss in the western world. Diabetic retinal lesions are still reversible at this stage opening entirely new opportunities for effective intervention. Four main alterations characterize these early stages of diabetic retinopathy: microaneurysms/hemorrhages, alteration of the blood-retinal barrier, capillary closure and alterations in the neuronal and glial cells of the retina. These alterations may be monitored by red-dot counting on eye fundus images and by fluorescein leakage and retinal thickness measurements. A combination of these methods through multimodal macula mapping has contributed by identifying three different phenotypes of diabetic retinopathy. They show different types and rates of progression which suggest the involvement of different susceptibility genes. The identification of different phenotypes opens the door for genotype characterization, different management strategies targeted treatments.

Entities:  

Mesh:

Year:  2004        PMID: 15708833     DOI: 10.1016/j.preteyeres.2004.07.004

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  32 in total

1.  Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes.

Authors:  Wendy W Harrison; Marcus A Bearse; Jason S Ng; Nicholas P Jewell; Shirin Barez; Dennis Burger; Marilyn E Schneck; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-09       Impact factor: 4.799

Review 2.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 3.  A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Authors:  Marcus A Bearse; Anthony J Adams; Ying Han; Marilyn E Schneck; Jason Ng; Kevin Bronson-Castain; Shirin Barez
Journal:  Prog Retin Eye Res       Date:  2006-09-01       Impact factor: 21.198

4.  Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.

Authors:  W-Y Shen; C M Lai; C E Graham; N Binz; Y K Y Lai; J Eade; D Guidolin; D Ribatti; S A Dunlop; P E Rakoczy
Journal:  Diabetologia       Date:  2006-05-10       Impact factor: 10.122

Review 5.  Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.

Authors:  Marcus A Bearse; Glen Y Ozawa
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

6.  Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases.

Authors:  Junghyun Kim; Chan-Sik Kim; Yun Mi Lee; Kyuhyung Jo; So Dam Shin; Jin Sook Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-17       Impact factor: 3.117

7.  Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.

Authors:  Dongjoon Kim; Robert P Mecham; Ngan-Ha Nguyen; Sayon Roy
Journal:  Exp Eye Res       Date:  2019-05-06       Impact factor: 3.467

Review 8.  [Unmet research and developmental needs in ophthalmology : A consensus-based road map of the European Vision Institute for 2019-2025].

Authors:  C Cursiefen; F Cordeiro; J Cunha-Vaz; T Wheeler-Schilling; H P N Scholl
Journal:  Ophthalmologe       Date:  2019-09       Impact factor: 1.059

9.  Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice.

Authors:  Junghyun Kim; Chan-Sik Kim; Ik Soo Lee; Yun Mi Lee; Eunjin Sohn; Kyuhyung Jo; Joo Hwan Kim; Jin Sook Kim
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

10.  Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway.

Authors:  Bin Zhang; Kevin K Zhou; Jian-xing Ma
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.